iData Research, a global consulting and market research firm, has released exclusive research in the European dental bone graft substitute market, addressing key insights and the consequences of COVID-19 in 2020, 2021, and beyond. While the overall market experienced a sharp economic contraction due to the COVID-19 pandemic, iData forecasts that the growth in allograft products, demographic factors, technological developments, and more will encourage significant growth.
According to iData’s European Dental Bone Graft Substitute Report, the European market was estimated at just over €151 million in 2020. The 2020 market value experienced a 31% decrease from €219 million in 2019, following COVID-19 headwinds. However, the market has started to recover moving into 2021 and is expected to exceed €277 million by 2027. This report includes unit sales, average selling prices, market drivers and limiters, competitive market share analysis, procedure numbers, and more.
iData’s analysis includes dental bone graft substitutes, dental growth factors, and dental barrier membranes (DBMs). As patient demand for dental implant procedures, quantified by iData, increases, the potential number of cases that require a bone grafting procedure also increases. This, in turn, generates demand for dental bone graft substitutes, barrier membranes and dental growth factor products, such as Emdogain®. A major trend in the dental bone graft substitute and other biomaterials market is the growth of allograft products in Europe. Most countries are experiencing double-digit growth in allograft products due to their effectiveness.
“There has been a growing volume of dental implant procedures being performed both as a result of demand from patients and an increasing number of general practitioners providing these services”, says Dr. Kamran Zamanian, Senior Partner and CEO of iData Research, “This is subsequently driving the total markets for dental bone graft substitutes and other biomaterials.”
Among the many competitors within these markets, Geistlich, Botiss Biomaterials, and Zimmer Biomet are the leaders followed by Straumann Group, ACE Surgical, and Bioteck. Non-profit tissue banks are also present within this market as they are generally involved in the production and distribution of allograft bone graft materials across Europe. Most countries in Europe have a network of non-profit tissue banks that collect and process allograft tissue for both dental and orthopedic use.
To accurately estimate market shares, units sold, average selling prices, product segments, and brands as well as procedural volumes, iData Research uses its proprietary market and procedure databases, as well as hospital purchase order data to complement its primary and secondary research initiatives.
Follow the link below to download a Free Research Summary of the European Dental Bone Graft Substitute Market:
For Further Information
More insights like this can be found in the latest reports by iData. Please email us at email@example.com or register online for a brochure and synopsis.